Genetic thrombophilia variants and risk for preeclampsia among American Indians

Hypertension in Pregnancy

Volumn 28, Issue 1, 2009, Pages 85-94

  Best, Lyle G ^a,e   Dorsam, Sheri T ^b   Nadeau, Melanie ^a   Burd, Larry ^c   Anderson, Cindy M ^d  

^a Turtle Mountain Community College   (United States)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH DAKOTA   (United States)

^d UNIVERSITY OF NORTH DAKOTA   (United States)

^e NONE   (United States)

Author keywords

American Indian; Factor V Leiden; Genetics; Pre eclampsia; Prothrombin 20210 polymorphism

Indexed keywords

ADULT; ALLELE; AMERICAN INDIAN; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREVALENCE; PROTEINURIA; RISK ASSESSMENT; THROMBOPHILIA;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENOTYPE; HUMANS; INDIANS, NORTH AMERICAN; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA; YOUNG ADULT;

EID: 60749128922     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950802419887     Document Type: Article

References (36)

1. Gammill HS, Roberts JM. Emerging concepts in preeclampsia investigation. Front Biosci 2007; 12:2403-2411.
2. Ilekis JV, Reddy UM, Roberts JM. Preeclampsia - a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007; 14:508-523.
3. Levy MT, Jacober SJ, Sowers JR. Hypertensive disorders of pregnancy in southwestern Navajo Indians. Arch Intern Med 1994; 154:2181-2183.
4. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77:67-75.
5. Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986; 93:898-908.
6. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4:59-61.
7. Arngrimsson R, Björnsson S, Geirsson RT, Björnsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990; 97:762-769.
8. Bertina R M. Koeleman B P C. Koster T. Rosendaal F R. Dirven R J. de Ronde H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
9. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994; 343:1361-1362.
10. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346:1133-1134.
11. Cox MJ, Rees DC, Martinson JJ, Clegg JB. Evidence for a single origin of factor V Leiden. Br J Haematol 1996;92:1022-1025.
12. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002;87:1095-1108.
13. Donahue BS, Gailani D, Higgins MS, Drinkwater DC, George AL Jr. Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation 2003; 107:1003-1008.
14. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996; 175:902-5.
15. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, et al. Thromb Haemost 1997; 77:1052-1054.
16. Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005; 105:182-192.
17. GOPEC Consortium. Disentangling fetal and maternal susceptibility for preeclampsia: a British multicenter candidate-gene study. Am J Hum Genet 2005; 77:127-131.
18. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3-prime-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703.
19. Roberts JM, Pearson G, Cutler J, Lindheimer M; NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41:437-445.
20. Bodnar LM, Catov JM, Roberts JM. Racial/ethnic differences in the monthly variation of preeclampsia incidence. Am J Obstet Gynecol 2007;196:324.e1-5.
21. Conde-Agudelo A, Althabe F, Belizán JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 1999; 181:1026-1035.
22. Hegele RA, Harris SB, Cao H, Hanley AJ, Zinman B. Factor V Leiden (F5 Q506) and vascular disease in Canadian Oji-Cree. Diabetes Care 1998;21:1203.
23. Kohler HP, Boothby M, McCormack L, Knowler WC, Grant PJ. Incidence of Arg506 - > Gln mutation (factor V Leiden) in Pima Indians. Thromb Haemost 1997;78:961-962.
24. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277:1305-1307.
25. Gregg JP, Yamane AJ, Grody WW. Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. Am J Med Genet 1997;73:334-346.
26. deMaat MPM, Kluft C, Jespersen J. World Distribution of factor V Leiden mutation. Lancet 1996; 347:58.
27. Souto JC, Coll I, Llobet D, del Río E, Oliver A, Mateo J, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998; 80:366-369.
28. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79:706-708.
29. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999; 99:999-1004.
30. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A 2004; 130:365-371.
31. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340:9-13. Erratum in: N Engl J Med 1999; 341:384.
32. De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, et al. Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 1999; 181:975-980.
33. Kim YJ, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Peraud PJ, et al. Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for ethylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am J Obstet Gynecol 2001; 184:1211-1217.
34. Robertson L, Wu O, Greer I. Thrombophilia and adverse pregnancy outcome. Curr Opin Obstet Gynecol 2004; 16:453-458.
35. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004; 91:700-711.
36. Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond) 2006; 110:443-458.